LOLAHEALTH
Treatment comparisons

Weight

Semaglutide and tirzepatide injections

Two weekly injectable options compared by pathway, labeling, considerations, and monitoring, with no declared winner.

For general education only. This information does not diagnose a condition or replace medical advice. Your provider will determine which evaluation or treatment is appropriate for you.

Side by side

Considerations worth bringing to your provider. This is not a ranking, and it does not mean any option is right for you.

Semaglutide injection

Product details
What it is
A medicine that acts on the GLP-1 hormone pathway involved in appetite, fullness, and blood sugar regulation.
How it is used
Injected once a week on a regular day. Your provider explains the routine and what to do about a missed dose.
Approval and labeling
Approved uses differ by product and brand. Some semaglutide products carry a weight management indication and others are labeled for diabetes. Ask which product is offered.
What the evidence supports
In studies, this class supported weight change alongside nutrition and activity. Response varies, and no result is guaranteed.
Common considerations
Nausea, vomiting, diarrhea, or constipation are common, especially early. Discuss how you will manage them.
Often not appropriate when
There is a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Tell your provider about pancreatitis history and all medicines.
Cost and access
Pricing is shared after your evaluation. Ask what your plan includes, such as consultations, medication, labs, and follow up, and what happens if your plan changes.

Tirzepatide injection

Product details
What it is
A medicine that acts on two pathways, GIP and GLP-1, both involved in appetite and metabolism.
How it is used
Injected once a week on a regular day. Your provider explains the routine and what to do about a missed dose.
Approval and labeling
Approved uses differ by product and brand. Some tirzepatide products carry a weight management indication and others are labeled for diabetes. Ask which product is offered.
What the evidence supports
In studies, this class supported weight change alongside nutrition and activity. Head to head comparisons between classes are not the same as a recommendation for you.
Common considerations
Nausea, vomiting, diarrhea, or constipation are common, especially early. Discuss how you will manage them.
Often not appropriate when
There is a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Tell your provider about pancreatitis history and all medicines.
Cost and access
Pricing is shared after your evaluation. Ask what your plan includes, such as consultations, medication, labs, and follow up, and what happens if your plan changes.

Questions to bring

  • Which exact product and formulation are you offering me?
  • Is the use you are proposing approved, off label, or compounded?
  • What side effects should prompt a call, and what is the plan if they persist?
  • How long is a reasonable trial before we reassess, and what happens if I stop?